Vector-Borne Infections
R-Biopharm Australia provides advanced vector-borne infection testing solutions for the rapid, reliable detection of viral, bacterial and protozoan pathogens transmitted by mosquitoes, ticks and other arthropod vectors. Using highly sensitive multiplex PCR technology, our molecular diagnostic panels enable comprehensive detection of vector-borne infections from a single sample, supporting infectious disease surveillance, epidemiological research and public health programmes. Covering clinically and epidemiologically significant pathogens including dengue virus, Zika virus, chikungunya virus, Japanese encephalitis virus, Ross River virus and Plasmodium species, our assays deliver fast, accurate results while streamlining laboratory workflows and reducing turnaround times. Combined with automated extraction solutions and integrated PCR technology, our vector-borne infections testing portfolio provides an efficient end-to-end workflow for research, reference and public health laboratories.
Comprehensive Molecular Detection of Vector-Borne Pathogens
Vector-borne infections present unique diagnostic challenges due to the diversity of pathogens involved and the overlap of clinical symptoms between different diseases. R-Biopharm Australia’s multiplex PCR solutions enable laboratories to simultaneously detect a broad range of viral, bacterial and protozoan targets, providing a more comprehensive understanding of complex infection profiles.
Designed to support surveillance, research and specialised diagnostic applications, our vector-borne infection testing panels deliver valuable molecular insights to help laboratories investigate emerging threats, monitor pathogen circulation and make informed decisions in a changing global health landscape.
Vector-Borne Infections Testing Portfolio
Vector-Borne Infections
Combinations of viral, bacterial, and protozoan targets with Artemisinin resistance to rapidly inform clinical interventions.
Parasites
- Plasmodium spp.
Resistance Genes
- Artemisenin resistance SNP C580Y in Plasmodium spp.
Viruses
- Dengue Virus 1
- Dengue Virus 2
- Dengue Virus 3
- Dengue Virus 4
- Barmah Forest Virus
- Chikungunya Virus
- Japanese Encephalitis
- Kunjin virus
- Murray Valley Encephalitis Virus
- Ross River Virus
- West Nile virus
- Zika Virus
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 27157S | RIDA®Plex Mosquito-Borne Infections 16 well Step 1 | 12 x 8-well Strips | 96 |
| 27157P | RIDA®Plex Mosquito-Borne Infections 16 well Step 2 | 12 x 384-well Plates | 288 |
| 40331 | RIDA®Plex L RNA Cassette | 10 Cassettes | – |
| 91600 | RIDA®Plex Positive Control Vector-Borne Panels | 10 x 2mL Tubes | – |
Designed for Research & Public Health Laboratories
Our vector-borne infection testing solutions are designed for research laboratories, public health laboratories and reference laboratories requiring rapid, comprehensive detection of vector-borne pathogens. Using advanced multiplex PCR technology, our assays simultaneously detect a broad range of viral, bacterial and protozoan pathogens from a single sample, supporting infectious disease surveillance, epidemiological research and outbreak investigations. By delivering fast, accurate molecular results, our solutions help laboratories improve workflow efficiency, increase diagnostic confidence and generate reliable data for vector surveillance and public health programmes.
Explore Our Technology
Our vector-borne infection testing portfolio combines automated nucleic acid extraction, advanced multiplex PCR instrumentation and integrated molecular diagnostic workflows to deliver rapid, comprehensive detection of mosquito-borne, tick-borne and other vector-borne pathogens. Designed for research, surveillance and public health laboratories, these solutions reduce hands-on time, improve laboratory efficiency and provide reliable molecular data to support monitoring, outbreak response and ongoing vector-borne infection research.
RIDA®Plex IVD panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European IVD Directive 98/79/EC. In the USA: For Research Use Only (RUO). For Research Use Only (RUO), not for use In diagnostic procedures. RIDA®Plex RUO panels are for Research Use Only in any jurisdiction.
